Cargando…

Calcinosis and lipodystrophy: clinical presentation of 10 years non-treated juvenile dermatomyositis – case report

Detalles Bibliográficos
Autores principales:	Velma, Selmanovic-Mulaosmanovic, Aida, Dizdarevic-Omercahic, Amela, Mornjakovic-Franca, Adisa, Cengic
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3194720/ http://dx.doi.org/10.1186/1546-0096-9-S1-P60

Ejemplares similares

Macrophage activation syndrome in children with systemic juvenile idiopathic arthritis: a retrospective study on 7 patients
por: Dizdarevic, Aida Omercahic, et al.
Publicado: (2014)

Forever interesting disease: Kawasaki vasculitis – case series
por: Selmanovic, Velma, et al.
Publicado: (2014)

Fulminant skin necrosis and massive deep venous thrombosis as a part of a clinical presentation of polyarteritis nodosa -case report
por: Čengić, Adisa, et al.
Publicado: (2014)

PReS-FINAL-2282: Amaurosis as a presenting sign of antiphospholipid syndrome secondary to systemic lupus erythematosus - case report
por: Omerčahić-Dizdarević, A, et al.
Publicado: (2013)

PReS-FINAL-2308: Catatonia due to systemic lupus erythematosus: characteristics and 36 months follow up of this rare manifestation of disease
por: Selmanovic (Mulaosmanovic), V, et al.
Publicado: (2013)

PReS-FINAL-2017: Systemic onset juvenile idiopathic arthritis (SOJIA)-a 5-year survey in a pediatric rheumatology department
por: Čengić, A, et al.
Publicado: (2013)

Treatment of calcinosis with biphosphonates in juvenile dermatomyositis
por: Bilginer, Y, et al.
Publicado: (2008)

Calcinosis as a complication of juvenile dermatomyositis (JDM)
por: Clara, Malagón, et al.
Publicado: (2011)

Interleukin-1 receptor antagonist treatment revealed active hepatitis B infection in a boy with PAPA syndrome
por: Selmanovic, V, et al.
Publicado: (2015)

PReS-FINAL-2013: Sodium thiosulfate for the treatment of Juvenile Dermatomyositis complicated by calcinosis
por: Pagnini, I, et al.
Publicado: (2013)

Calcinosis Universalis in Juvenile Dermatomyositis
por: Chung, Chong Hyuk
Publicado: (2020)

46 Universal calcinosis in juvenile dermatomyositis: a case report
por: Bahaz, N, et al.
Publicado: (2022)

PReS-FINAL-2014: Excellent results of the conventional treatment in a child with late-diagnosed juvenile dermatomyositis with severe calcinosis
por: Nikishina, IP, et al.
Publicado: (2013)

Calcinosis in juvenile dermatomyositis: Updates on pathogenesis and treatment
por: Pinotti, Caitlan S., et al.
Publicado: (2023)

Juvenile dermatomyositis associated to lymphoepithelioma, a nasopharyngeal carcinoma
por: Bica, BERG, et al.
Publicado: (2011)

Gastroparesis associated with Juvenile Dermatomyositis
por: Martin, N, et al.
Publicado: (2008)

Respiratory involvement in juvenile dermatomyositis
por: Fabi, M, et al.
Publicado: (2008)

Juvenile dermatomyositis in Western Switzerland
por: Enders, F Bellutti, et al.
Publicado: (2011)

Thrombotic microangiopathy in juvenile dermatomyositis
por: Frolenko, A, et al.
Publicado: (2011)

Regulatory B cell Il-10 production is diminished in juvenile dermatomyositis
por: Piper, Christopher, et al.
Publicado: (2014)

Tumoral Calcinosis as an Initial Complaint of Juvenile-Onset Amyopathic Dermatomyositis
por: Doh, Eun Jin, et al.
Publicado: (2016)

Treatment of refractory juvenile dermatomyositis with tacrolimus
por: Hassan, J, et al.
Publicado: (2008)

Dyslipidemia in active juvenile dermatomyositis patients
por: Kozu, KT, et al.
Publicado: (2011)

Juvenile dermatomyositis (JDM) sine myositis
por: Schuetz, C, et al.
Publicado: (2011)

Subclinical pulmonary abnormalities in juvenile dermatomyositis
por: Sallum, Adriana M, et al.
Publicado: (2014)

Potential association of LMNA-associated generalized lipodystrophy with juvenile dermatomyositis
por: Sahinoz, Melis, et al.
Publicado: (2018)

Evaluation of the cardiovascular system in patients with juvenile dermatomyositis
por: Opoka – Winiarska, Violetta, et al.
Publicado: (2011)

The PRINTO provisional definition of remission in juvenile dermatomyositis
por: Lazarevic, D, et al.
Publicado: (2011)

The role of etanercept in juvenile dermatomyositis (JDMS) in children
por: Green, Katherine L, et al.
Publicado: (2014)

PReS-FINAL-2012: Introducing a new approach to clinical care of juvenile dermatomyositis: the juvenile dermatomyositis multidimensional assessment report
por: Varnier, GC, et al.
Publicado: (2013)

Autoantibodies to a 140-kd protein in juvenile dermatomyositis are associated with calcinosis
por: Gunawardena, H, et al.
Publicado: (2009)

Clinical phenotypes and biologic treatment use in juvenile dermatomyositis-associated calcinosis
por: Orandi, Amir B., et al.
Publicado: (2018)

Role of mitochondria in the myopathy of juvenile dermatomyositis and implications for skeletal muscle calcinosis
por: Duvvuri, Bhargavi, et al.
Publicado: (2023)

Juvenile dermatomyositis: clinical and laboratory charateristics of 18 patients
por: Iglesias, E, et al.
Publicado: (2011)

PReS-FINAL-2131: Hunting for biomarkers in juvenile dermatomyositis
por: Bellutti Enders, F, et al.
Publicado: (2013)

Sleep, fatigue and quality of life in juvenile idiopathic arthritis (JIA) and Juvenile Dermatomyositis (JDM)
por: Avie, Y Butbul, et al.
Publicado: (2008)

CD4(+)FOXP3(+) regulatory T cells are abundantly present in inflamed muscle of patients with juvenile dermatomyositis
por: Vercoulen, Yvonne, et al.
Publicado: (2011)

8.3 Disease patterns in Danish Juvenile Dermatomyositis patients
por: Mathiesen, PR, et al.
Publicado: (2008)

What is the mortality of Juvenile Dermatomyositis (JDM) in the modern treatment era
por: Smith, S, et al.
Publicado: (2008)

Disease patterns in juvenile dermatomyositis patients from Mumbai, India
por: Khubchandani, RP, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_cg97cv4l52penvg7b1l8bghfvp